Udenafil
From Wikipedia, the free encyclopedia
|
Udenafil
|
|
| Systematic (IUPAC) name | |
| 3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-5-yl)
-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -4-propoxybenzenesulfonamide |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C25H36N6O4S |
| Mol. mass | 516.657 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Udenafil is a drug used in urology to treat erectile dysfunction.
|
|||||||||||||||||
|
|||||||||||||||||

